Institutional Fund
Royalty Pharma Sub-Manager, LLC
New York, NYCIK 20816682 filings on record
Portfolio Value
$172.76M
Q1 2026
Holdings
4
Reported positions
New Buys
0
Opened this quarter
QoQ Change
+0.8%
from $171.31M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Cytokinetics Inc37.4%
- Bicara Therapeutics Inc27.0%
- Biocryst Pharmaceuticals Inc21.2%
- Biohaven Ltd14.4%
Portfolio Holdings
4 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Cytokinetics Inc | 980.4K | $64.62M | 37.4% | 0 | Held |
| 2 | Bicara Therapeutics Inc | 2.39M | $46.69M | 27.0% | +1.13M | Added |
| 3 | Biocryst Pharmaceuticals Inc | 3.85M | $36.62M | 21.2% | 0 | Held |
| 4 | Biohaven Ltd | 2.94M | $24.84M | 14.4% | 0 | Held |